These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Neuroimaging Findings in Patients with Mucopolysaccharidosis: What You Really Need to Know. Reichert R; Campos LG; Vairo F; de Souza CF; Pérez JA; Duarte JÁ; Leiria FA; Anés M; Vedolin LM Radiographics; 2016; 36(5):1448-62. PubMed ID: 27618324 [TBL] [Abstract][Full Text] [Related]
50. International guidelines for the management and treatment of Morquio A syndrome. Hendriksz CJ; Berger KI; Giugliani R; Harmatz P; Kampmann C; Mackenzie WG; Raiman J; Villarreal MS; Savarirayan R Am J Med Genet A; 2015 Jan; 167A(1):11-25. PubMed ID: 25346323 [TBL] [Abstract][Full Text] [Related]
51. Intracranial tumor in a patient with mucopolysaccharidosis type 1 (Scheie syndrome): An extremely rare combination. Kukreja S; Soomro AI; Lohana S; Kalwar A; Ochani S; Rachna ; Hasibuzzaman MA Heliyon; 2024 Oct; 10(19):e38652. PubMed ID: 39397911 [TBL] [Abstract][Full Text] [Related]
52. Atypical Neuroimaging Findings in a Patient With Mucopolysaccharidosis Type VII (Sly Syndrome). Lamghare PK; Agarwal U; Kalekar T; Krishnani KS Cureus; 2024 Aug; 16(8):e66819. PubMed ID: 39280482 [TBL] [Abstract][Full Text] [Related]
53. Mucopolysaccharidosis Type 1 among Children-Neuroradiological Perspective Based on Single Centre Experience and Literature Review. Machnikowska-Sokołowska M; Myszczuk A; Wieszała E; Wieja-Błach D; Jamroz E; Paprocka J Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837830 [TBL] [Abstract][Full Text] [Related]
54. Increased ocular wall thickness and decreased globe volume in children with mucopolysaccharidosis type VI. Ozkale Yavuz O; Ayaz E; Yıldız Y; Akgoz Karaosmanoglu A; Bulut E; Kalkanoglu Sivri HS; Oguz KK Diagn Interv Radiol; 2022 Sep; 28(5):516-521. PubMed ID: 36218154 [TBL] [Abstract][Full Text] [Related]
55. Adjunct diagnostic value of radiological findings in mucopolysaccharidosis type IVa-related thoracic spinal abnormalities: a pilot study. Jan YT; Tsai PS; Huang WH; Huang SC; Liu YP; Cheng SM; Huang KS Orphanet J Rare Dis; 2022 Jul; 17(1):296. PubMed ID: 35906705 [TBL] [Abstract][Full Text] [Related]
56. Diagnosis and Management of Genetic Causes of Middle Aortic Syndrome in Children: A Comprehensive Literature Review. Lazea C; Al-Khzouz C; Sufana C; Miclea D; Asavoaie C; Filimon I; Fufezan O Ther Clin Risk Manag; 2022; 18():233-248. PubMed ID: 35330917 [TBL] [Abstract][Full Text] [Related]
57. Functioning profiles of individuals with Mucopolysaccharidosis according to the International Classification of Functioning. Bernardo Figueirêdo B; de Sousa Dantas D; Oliveira TG; Cavalcanti GD; Reinaux C; Dornelas de Andrade A Eur J Phys Rehabil Med; 2022 Feb; 58(1):127-136. PubMed ID: 34468112 [TBL] [Abstract][Full Text] [Related]
58. Reactive Oxygen Species and Oxidative Stress in the Pathogenesis and Progression of Genetic Diseases of the Connective Tissue. Egea G; Jiménez-Altayó F; Campuzano V Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33086603 [TBL] [Abstract][Full Text] [Related]
59. Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology. Hampe CS; Eisengart JB; Lund TC; Orchard PJ; Swietlicka M; Wesley J; McIvor RS Cells; 2020 Aug; 9(8):. PubMed ID: 32764324 [TBL] [Abstract][Full Text] [Related]
60. Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes. Hendrickx G; Danyukova T; Baranowsky A; Rolvien T; Angermann A; Schweizer M; Keller J; Schröder J; Meyer-Schwesinger C; Muschol N; Paganini C; Rossi A; Amling M; Pohl S; Schinke T Hum Mol Genet; 2020 Mar; 29(5):803-816. PubMed ID: 31943020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]